EUVIMEDEUVIMED entdecken
Crossref

Optimization of the radiolabelling of pertuzumab with terbium-161

T. Janská, M. Vlk, K. Nováková, Z. Nový, K. Hajduová, P. Bárta, F. Trejtnar, J. Kozempel

Journal of Radioanalytical and Nuclear Chemistry · 17.11.2026

DOI: 10.1007/s10967-026-11299-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radioanalytical and Nuclear Chemistry, online erschienen am 17.11.2026. Verfasst von T. Janská und 7 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Czech Health Research Council, CTU in Prague, Ministry of Education, Youth and Sports, Czech Republic.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Czech Health Research Council
  • CTU in Prague
  • Ministry of Education, Youth and Sports, Czech Republic

Zitieren

APA

Janská, T., Vlk, M., Nováková, K., Nový, Z., Hajduová, K., Bárta, P., Trejtnar, F., & Kozempel, J. (2026). Optimization of the radiolabelling of pertuzumab with terbium-161. Journal of Radioanalytical and Nuclear Chemistry. https://doi.org/10.1007/s10967-026-11299-9

Vancouver

Janská T, Vlk M, Nováková K, Nový Z, Hajduová K, Bárta P, et al. Optimization of the radiolabelling of pertuzumab with terbium-161. Journal of Radioanalytical and Nuclear Chemistry. 2026. doi:10.1007/s10967-026-11299-9

BibTeX
@article{Jansk2026,
  author = {Janská, T. and Vlk, M. and Nováková, K. and Nový, Z. and Hajduová, K. and Bárta, P. and Trejtnar, F. and Kozempel, J.},
  title = {Optimization of the radiolabelling of pertuzumab with terbium-161},
  journal = {Journal of Radioanalytical and Nuclear Chemistry},
  year = {2026},
  doi = {10.1007/s10967-026-11299-9}
}
Kostenlos starten →